Standout Papers

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjuga... 2014 2026 2018 2022 385
  1. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study (2014)
    Nick Andrews, Pauline A. Waight et al. The Lancet Infectious Diseases

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
The immunostimulatory nature of mRNA lipid nanoparticles
2024 Standout
2 intermediate papers

Works of Lucy Roalfe being referenced

Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation
2022
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
2014 Standout

Author Peers

Author Last Decade Papers Cites
Lucy Roalfe 563 198 86 19 657
Heidi Åhman 610 394 82 15 676
Anu Soininen 690 329 93 17 751
J. E. Groover 669 225 217 11 788
Pierre Tellier 520 105 54 13 666
Diana Hu 443 177 133 15 804
I. D. Allan 500 213 46 15 644
Dorothee Kieninger 666 468 86 16 756
Franklin Sotolongo 635 637 88 25 727
Ray Borrow 550 570 63 37 652
P. H. Makela 524 430 84 13 772

All Works

Loading papers...

Rankless by CCL
2026